Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Precision Peptide CoPNGAF +6.25%22 EV-to-EBIT is -6.33 as of Jul. 24, 2026. GuruFocus rates PNGAF with a GF Score™ of 22/100. The stock has 4 warning signs investors should review. Among 1,559 Consumer Packaged Goods companies, The Precision Peptide Co ranks worse than 64143.62% on this metric.
The Precision Peptide Co (OTCPK:PNGAF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
The Precision Peptide Co's Enterprise Value for the quarter that ended in Apr. 2026 was $14.96 Mil.
The Precision Peptide Co's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.68 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Precision Peptide Co EV-to-EBIT Related Terms
The Precision Peptide Co EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, The Precision Peptide Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Precision Peptide Co EV-to-EBIT vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, The Precision Peptide Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where The Precision Peptide Co's EV-to-EBIT falls into.
The Precision Peptide Co's current Enterprise Value is $16.98 Mil.
The Precision Peptide Co's EBIT for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.68 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Precision Peptide Co (PNGAF) has a EV-to-EBIT of -6.33 as of Jul. 24, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on The Precision Peptide Co and its competitors. According to the industry distribution chart, The Precision Peptide Co ranks #999999 out of 1559 companies in the Consumer Packaged Goods industry.
Is The Precision Peptide Co's EV-to-EBIT too high?
The Precision Peptide Co's current EV-to-EBIT is -6.33. Based on the distribution chart, The Precision Peptide Co ranks #999999 out of 1559 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, The Precision Peptide Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's EV-to-EBIT compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, The Precision Peptide Co ranks #999999 out of 1559 companies for EV-to-EBIT. This places The Precision Peptide Co in the lower half of its industry. The industry median EV-to-EBIT is 12.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Consumer Packaged Goods company?
The median EV-to-EBIT among Consumer Packaged Goods companies is 12.11, based on 1,559 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on The Precision Peptide Co and its competitors. For the Consumer Packaged Goods industry, the median EV-to-EBIT is 12.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Precision Peptide Co's current EV-to-EBIT is -6.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (PNGAF) has a current EV-to-EBIT of -6.33. The current EV-to-EBIT is -6.33. The Precision Peptide Co's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For The Precision Peptide Co (PNGAF), the current EV-to-EBIT is -6.33 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
22GF Score
Get the complete analysis for PNGAF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PNGAF has been successfully added to your 
